Prostate cancer: 3. Individual risk factors.
作者信息
Gallagher R P, Fleshner N
机构信息
Cancer Control Research Program, British Columbia Cancer Agency, Vancouver.
出版信息
CMAJ. 1998 Oct 6;159(7):807-13.
Abstract
摘要
相似文献
1
Prostate cancer: 3. Individual risk factors.前列腺癌：3. 个体风险因素。
CMAJ. 1998 Oct 6;159(7):807-13.
2
Epidemiology of prostate cancer.前列腺癌的流行病学
West J Med. 1998 Aug;169(2):111-2.
3
Epidemiology of prostate cancer: molecular and environmental clues.前列腺癌的流行病学：分子与环境线索
Urology. 1996 Nov;48(5):676-83. doi: 10.1016/S0090-4295(96)00219-1.
4
Changing demography of prostate cancer in Asia.亚洲前列腺癌人口统计学的变化。
Eur J Cancer. 2005 Apr;41(6):834-45. doi: 10.1016/j.ejca.2004.12.033.
5
Sun exposure may confound physical activity-prostate cancer association.阳光照射可能会混淆身体活动与前列腺癌之间的关联。
Arch Intern Med. 2005 Nov 28;165(21):2538-9; author reply 2539-40. doi: 10.1001/archinte.165.21.2538-c.
6
[Prostate cancer--incidence and risk factors].[前列腺癌——发病率及风险因素]
Ugeskr Laeger. 2007 May 14;169(20):1883-6.
7
Prostate cancer risk factors.前列腺癌风险因素。
Harv Mens Health Watch. 2004 Feb;8(7):1-3.
8
Prostate cancer.前列腺癌
N Engl J Med. 2003 Jul 24;349(4):366-81. doi: 10.1056/NEJMra021562.
9
[The epidemiology of prostate cancer--recent trends in prostate cancer incidence and mortality].[前列腺癌的流行病学——前列腺癌发病率和死亡率的近期趋势]
Gan To Kagaku Ryoho. 2001 Feb;28(2):184-8.
10
Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study.芬兰男性的代谢综合征与前列腺癌风险：一项基于人群的研究。
Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1646-50.
引用本文的文献
1
Flavones: The Apoptosis in Prostate Cancer of Three Flavones Selected as Therapeutic Candidate Models.类黄酮：三种类黄酮作为治疗候选模型在前列腺癌中的细胞凋亡作用。
Int J Mol Sci. 2023 May 25;24(11):9240. doi: 10.3390/ijms24119240.
2
Carriage of mutations R462Q (rs 486907) and D541E (rs 627928) of the RNASEL gene and risk factors in patients with prostate cancer in Burkina Faso.RNASEL 基因 R462Q(rs486907)和 D541E(rs627928)突变的携带情况与布基纳法索前列腺癌患者的危险因素。
BMC Med Genomics. 2022 Jun 2;15(1):123. doi: 10.1186/s12920-022-01279-9.
3
Prostate cancer: Therapeutic prospect with herbal medicine.前列腺癌：草药治疗前景
Curr Res Pharmacol Drug Discov. 2021 Jul 8;2:100034. doi: 10.1016/j.crphar.2021.100034. eCollection 2021.
4
Epidemiology, Staging and Management of Prostate Cancer.前列腺癌的流行病学、分期与管理
Med Sci (Basel). 2020 Jul 20;8(3):28. doi: 10.3390/medsci8030028.
5
Epidemiology of Prostate Cancer.前列腺癌流行病学
World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20.
6
Role of vitamin D receptor gene Cdx2 and Apa1 polymorphisms in prostate cancer susceptibility: a meta-analysis.维生素D受体基因Cdx2和Apa1多态性在前列腺癌易感性中的作用：一项荟萃分析。
BMC Cancer. 2016 Aug 23;16(1):674. doi: 10.1186/s12885-016-2722-2.
7
High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.DDX20的高表达通过NF-κB途径增强前列腺癌细胞的增殖和转移潜能。
Int J Mol Med. 2016 Jun;37(6):1551-7. doi: 10.3892/ijmm.2016.2575. Epub 2016 Apr 25.
8
Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.肿瘤抑制性微小RNA-145通过靶向人前列腺癌细胞中的SENP1诱导生长停滞。
Cancer Sci. 2015 Apr;106(4):375-82. doi: 10.1111/cas.12626. Epub 2015 Mar 16.
9
Genome-wide haplotype association study identifies BLM as a risk gene for prostate cancer in Chinese population.全基因组单倍型关联研究确定BLM为中国人群前列腺癌的一个风险基因。
Tumour Biol. 2015 Apr;36(4):2703-7. doi: 10.1007/s13277-014-2893-x. Epub 2014 Dec 4.
10
PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines.PARP - 1和CASP3基因在LNCaP和PC - 3前列腺癌细胞系中上调。
Hum Cell. 2014 Oct;27(4):172-5. doi: 10.1007/s13577-013-0076-5. Epub 2014 Jul 19.
本文引用的文献
1
Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25.对49个高危家族进行的连锁分析并不支持在1q24 - 25存在常见的家族性前列腺癌易感基因。
Am J Hum Genet. 1997 Aug;61(2):347-53. doi: 10.1086/514853.
2
Height, body weight, and risk of prostate cancer.身高、体重与前列腺癌风险。
Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):557-63.
3
Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study.1号染色体上前列腺癌易感基因座：一项验证性研究。
J Natl Cancer Inst. 1997 Jul 2;89(13):955-9. doi: 10.1093/jnci/89.13.955.
4
Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States).爱荷华州65岁及以上农村健康研究（美国）中吸烟、体重和身体活动与前列腺癌风险的关联
Cancer Causes Control. 1997 Mar;8(2):229-38. doi: 10.1023/a:1018428531619.
5
Family history of prostate cancer: a multi-center case-control study in Canada.前列腺癌家族史：加拿大的一项多中心病例对照研究。
Int J Cancer. 1997 Mar 17;70(6):679-81. doi: 10.1002/(sici)1097-0215(19970317)70:6<679::aid-ijc9>3.0.co;2-s.
6
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.雄激素受体基因内的CAG重复序列及其与前列腺癌的关系。
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3320-3. doi: 10.1073/pnas.94.7.3320.
7
Diet and prostate cancer: a case-control study.饮食与前列腺癌：一项病例对照研究。
Eur J Cancer. 1997 Jan;33(1):101-7. doi: 10.1016/s0959-8049(96)00373-5.
8
Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.雄激素受体基因中的多态性重复序列：前列腺癌风险的分子标志物。
Cancer Res. 1997 Mar 15;57(6):1194-8.
9
Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.维生素D受体和雄激素受体基因多态性与前列腺癌风险的关联
J Natl Cancer Inst. 1997 Jan 15;89(2):166-70. doi: 10.1093/jnci/89.2.166.
10
Androgen and vitamin D receptor gene polymorphisms: the long and short of prostate cancer risk.雄激素与维生素D受体基因多态性：前列腺癌风险的长短因素
J Natl Cancer Inst. 1997 Jan 15;89(2):109-11. doi: 10.1093/jnci/89.2.109.
Zotero 插件